Join the 'Lymphangioleiomyomatosis' group to help and get support from people like you.
Related terms: LAM, Pulmonary Lymphangioleiomyomatosis
Posted 1 Jun 2015 by Drugs.com
May 28, 2015 – The U.S. Food and Drug Administration today approved Rapamune (sirolimus), to treat lymphangioleiomyomatosis (LAM), a rare, progressive lung disease that primarily affects women of childbearing age. This is the first drug approved to treat the disease. LAM is characterized by an abnormal growth of smooth muscle cells that invade lung tissues, including the airways, and ...